Leadership & Pay ·
Ironwood appoints Tammi Gaskins as CEO effective Jan 1, 2027; Tom McCourt to retire
IRWDIronwood Pharmaceuticals Inc
The Board of Directors appointed Senior Vice President and Chief Commercial Officer Tammi Gaskins as Chief Executive Officer and elected her to the Board, effective January 1, 2027. The Board also increased its size from eight to nine directors. Outgoing CEO Tom McCourt will retire on December 31, 2026, after 17 years with the company, and will remain a director while serving as a consultant for $10,000 per month. Gaskins receives an annual base salary of $775,000 and equity grants valued at approximately $4 million in total target value. Ironwood Pharmaceuticals is a biotechnology company developing and commercializing therapies for gastrointestinal and rare diseases.